Annual FCF
-$121.38 M
-$326.08 M-159.30%
December 31, 2023
Summary
- As of February 7, 2025, ABCL annual free cash flow is -$121.38 million, with the most recent change of -$326.08 million (-159.30%) on December 31, 2023.
- During the last 3 years, ABCL annual FCF has fallen by -$129.40 million (-1614.08%).
- ABCL annual FCF is now -159.30% below its all-time high of $204.70 million, reached on December 31, 2022.
Performance
ABCL Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$47.40 M
+$2.68 M+5.35%
September 30, 2024
Summary
- As of February 7, 2025, ABCL quarterly free cash flow is -$47.40 million, with the most recent change of +$2.68 million (+5.35%) on September 30, 2024.
- Over the past year, ABCL quarterly FCF has increased by +$2.68 million (+5.35%).
- ABCL quarterly FCF is now -119.61% below its all-time high of $241.69 million, reached on June 30, 2022.
Performance
ABCL Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$197.92 M
-$26.96 M-15.77%
September 30, 2024
Summary
- As of February 7, 2025, ABCL TTM free cash flow is -$197.92 million, with the most recent change of -$26.96 million (-15.77%) on September 30, 2024.
- Over the past year, ABCL TTM FCF has dropped by -$26.96 million (-15.77%).
- ABCL TTM FCF is now -169.02% below its all-time high of $286.77 million, reached on June 30, 2022.
Performance
ABCL TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ABCL Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -159.3% | +5.3% | -15.8% |
| 3 y3 years | -1614.1% | -226.8% | -193.3% |
| 5 y5 years | -6868.1% | - | - |
ABCL Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -159.3% | at low | -119.6% | +66.5% | -169.0% | at low |
| 5 y | 5-year | -159.3% | at low | -119.6% | +66.5% | -169.0% | at low |
| alltime | all time | -159.3% | at low | -119.6% | +66.5% | -169.0% | at low |
AbCellera Biologics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$47.40 M(-5.3%) | -$197.92 M(+15.8%) |
| Jun 2024 | - | -$50.08 M(-24.0%) | -$170.96 M(+33.4%) |
| Mar 2024 | - | -$65.85 M(+90.3%) | -$128.19 M(+5.6%) |
| Dec 2023 | -$121.38 M(-159.3%) | -$34.60 M(+69.3%) | -$121.38 M(+78.0%) |
| Sep 2023 | - | -$20.44 M(+180.0%) | -$68.20 M(-63.9%) |
| Jun 2023 | - | -$7.30 M(-87.6%) | -$189.06 M(-415.5%) |
| Mar 2023 | - | -$59.05 M(-417.8%) | $59.93 M(-70.7%) |
| Dec 2022 | $204.70 M | $18.58 M(-113.2%) | $204.70 M(+28.0%) |
| Sep 2022 | - | -$141.30 M(-158.5%) | $159.98 M(-44.2%) |
| Jun 2022 | - | $241.69 M(+181.9%) | $286.77 M(+72.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $85.72 M(-427.9%) | $165.96 M(-10.8%) |
| Dec 2021 | $186.13 M(+2221.7%) | -$26.14 M(+80.2%) | $186.13 M(-12.2%) |
| Sep 2021 | - | -$14.51 M(-112.0%) | $212.05 M(-3.1%) |
| Jun 2021 | - | $120.88 M(+14.1%) | $218.87 M(+82.0%) |
| Mar 2021 | - | $105.90 M(<-9900.0%) | $120.27 M(+1400.1%) |
| Dec 2020 | $8.02 M(-715.3%) | -$224.00 K(-97.1%) | $8.02 M(-2.7%) |
| Sep 2020 | - | -$7.69 M(-134.5%) | $8.24 M(-48.3%) |
| Jun 2020 | - | $22.27 M(-450.9%) | $15.93 M(-350.9%) |
| Mar 2020 | - | -$6.35 M | -$6.35 M |
| Dec 2019 | -$1.30 M(-25.2%) | - | - |
| Dec 2018 | -$1.74 M | - | - |
FAQ
- What is AbCellera Biologics annual free cash flow?
- What is the all time high annual FCF for AbCellera Biologics?
- What is AbCellera Biologics annual FCF year-on-year change?
- What is AbCellera Biologics quarterly free cash flow?
- What is the all time high quarterly FCF for AbCellera Biologics?
- What is AbCellera Biologics quarterly FCF year-on-year change?
- What is AbCellera Biologics TTM free cash flow?
- What is the all time high TTM FCF for AbCellera Biologics?
- What is AbCellera Biologics TTM FCF year-on-year change?
What is AbCellera Biologics annual free cash flow?
The current annual FCF of ABCL is -$121.38 M
What is the all time high annual FCF for AbCellera Biologics?
AbCellera Biologics all-time high annual free cash flow is $204.70 M
What is AbCellera Biologics annual FCF year-on-year change?
Over the past year, ABCL annual free cash flow has changed by -$326.08 M (-159.30%)
What is AbCellera Biologics quarterly free cash flow?
The current quarterly FCF of ABCL is -$47.40 M
What is the all time high quarterly FCF for AbCellera Biologics?
AbCellera Biologics all-time high quarterly free cash flow is $241.69 M
What is AbCellera Biologics quarterly FCF year-on-year change?
Over the past year, ABCL quarterly free cash flow has changed by +$2.68 M (+5.35%)
What is AbCellera Biologics TTM free cash flow?
The current TTM FCF of ABCL is -$197.92 M
What is the all time high TTM FCF for AbCellera Biologics?
AbCellera Biologics all-time high TTM free cash flow is $286.77 M
What is AbCellera Biologics TTM FCF year-on-year change?
Over the past year, ABCL TTM free cash flow has changed by -$26.96 M (-15.77%)